| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 163.81B | 159.96B | 154.56B | 153.35B | 131.12B | 116.66B |
| Gross Profit | 26.86B | 25.30B | 24.82B | 24.87B | 22.59B | 19.33B |
| EBITDA | 12.02B | 12.49B | 12.06B | 12.04B | 10.79B | 8.63B |
| Net Income | 6.15B | 6.53B | 6.17B | 6.70B | 5.74B | 3.89B |
Balance Sheet | ||||||
| Total Assets | 88.07B | 93.48B | 86.25B | 81.72B | 79.06B | 75.27B |
| Cash, Cash Equivalents and Short-Term Investments | 8.75B | 13.26B | 10.50B | 7.37B | 13.97B | 15.46B |
| Total Debt | 8.06B | 9.19B | 10.73B | 10.30B | 10.90B | 12.50B |
| Total Liabilities | 20.40B | 25.51B | 23.14B | 23.09B | 25.45B | 26.43B |
| Stockholders Equity | 67.67B | 67.97B | 63.11B | 58.62B | 53.61B | 48.83B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.89B | 4.70B | -3.47B | 1.40B | 8.06B |
| Operating Cash Flow | 0.00 | 7.33B | 7.72B | -1.21B | 3.62B | 11.03B |
| Investing Cash Flow | 0.00 | -849.00M | -2.88B | -1.62B | -3.19B | -3.00B |
| Financing Cash Flow | 0.00 | -3.42B | -2.00B | -2.77B | -2.93B | -2.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥771.10B | 19.01 | 19.13% | 2.64% | 7.58% | 15.12% | |
82 Outperform | ¥38.64B | 6.46 | ― | 5.21% | 3.66% | -6.67% | |
66 Neutral | ¥124.40B | 8.08 | ― | 2.82% | 11.66% | -7.47% | |
63 Neutral | ¥59.51B | 10.40 | ― | 4.49% | 8.56% | -13.47% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
53 Neutral | ¥227.89B | 16.36 | ― | 1.24% | 21.79% | 9.89% | |
48 Neutral | ¥4.45B | -10.59 | ― | 1.08% | -2.36% | -1738.42% |